The JFDA Cosmo Appointment System: Entry Point of Jordan Registration
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The procedural starting point of Jordan registration is the JFDA Cosmo electronic appointment system (application.jfda.jo/Cosmo). GRZAN’s conclusion is that this step is not a formal queue-and-ticket exercise but a substantive pre-review gateway for the materials — only by uploading the application form in the system and electronically attaching the required documents can the applicant obtain an appointment slot. Everything that follows — the SMS notification, the attendance date and the on-site delivery of originals — hangs on this electronic first step, which is why GRZAN treats the Cosmo stage as the operational hinge of the whole registration project.
- The second conclusion: Jordan uses a hybrid model of “electronic appointment plus on-site submission”. JFDA notifies the attendance date by SMS; on the appointment day, the merchant or the authorised agent must deliver the original documents in person to the Medical Devices and Medical Supplies Directorate.
- The third conclusion: the Cosmo system is expanding. The login interface of the system already explicitly covers cosmetics and medical consumables (Arabic: مواد التجميل والمستلزمات الطبية); at the same time, JFDA has listed the development of new electronic services and the automation of the work of the Medical Devices and Medical Supplies Directorate among its priorities for 2025–2027, so the degree of electronification will continue to rise.
2. Legal basis
| Name of regulation | Reference / number | Date of publication | Article number / provision |
| JFDA Cosmo electronic appointment system | application.jfda.jo/Cosmo | version currently in force | electronic appointment, document attachment and attendance notification procedures |
| Medical Devices Importation Directives Including Sterilizers & Detergents | Medical Devices Importation Directives Including Sterilizers & Detergents | version currently in force | registration application submission provisions |
| JFDA priorities for 2025–2027 | Jordan Government Budget Department, chapter 2704 | 2025 | second-priority paragraph (electronic system upgrades and the development of new electronic services) |
System procedures follow what is published on the official JFDA portal; article numbers are subject to the Arabic original of the official gazette of Jordan.
3. Expert insights
Insight 1: the appointment step has the character of a materials pre-review. Because the application form must be uploaded and the documents attached before an appointment slot can be obtained, Cosmo in effect performs a first completeness check. Applications with missing documents or non-conforming formats cannot enter the appointment queue. GRZAN recommends preparing the appointment application as if it were the first submission, not as an administrative formality. A failure at this stage is silent — there is no deficiency letter to answer, only an appointment that never arrives.
Insight 2: on-site submission requires originals. On the appointment day, the original documents must be delivered in person by the merchant or an authorised agent. This requirement determines that all documents requiring consular legalisation (the FSC, the letter of authorisation) must complete the entire legalisation process before the appointment date. A certificate that is still in the legalisation chain on the appointment day cannot be substituted with a copy, so the legalisation schedule and the appointment schedule have to be planned against each other from the outset.
Insight 3: the import approval step also requires the representative to be present. The JFDA import approval procedure published on the Jordan Trade Portal provides that the establishment’s designated representative or authorised representative must be present when the import documents are processed. This means the AR’s presence obligation runs through both the registration stage and the import stage. Companies should therefore check the AR’s availability for both kinds of appointments when they select the representative, not only for the registration submission.
Insight 4: digitalisation is the established direction. JFDA’s second-priority items include upgrading the existing electronic systems, developing new electronic services of no more than 160 services, and automating the issuance of electronic registration certificates. Companies should build up capacity for a fully electronic end-to-end process in the future. The practical implication for current projects is that document formats prepared today should already be clean, structured and reusable, so that they can migrate into whatever electronic workflow JFDA introduces next.
4. Practical recommendations
- Schedule the consular legalisation first. The notarisation and consular legalisation of the FSC and the letter of authorisation usually take 4 to 6 weeks (practical estimate); they should start before the Cosmo appointment application. Placing the legalisation chain first also protects the appointment itself: if the originals are ready when the slot is granted, the on-site delivery can proceed without a rebooking.
- Assign a dedicated person to track the SMS notification after the appointment. The attendance date is notified by SMS; missing it means rebooking the appointment, which directly pushes back the project milestones. The tracking arrangement should cover both the mobile number registered in the system and a backup reader, so that the notification is never missed because one person is on leave.
- Clarify who attends the on-site submission. Whether the merchant in person or an authorised agent attends must be agreed with the AR in advance, and the corresponding authorisation documents must be prepared. The authorisation documents themselves belong to the set of papers carried to the directorate on the day, so they must be finalised at the same time as the legalisation chain.
- Build an electronic document package. Pre-assembling the document package according to Cosmo’s format requirements can shorten the interval between the appointment and the submission.
5. Verification checklist
- □ Confirm the account and the appointment entitlement in the Cosmo system
- □ Upload the application form and electronically attach all required documents as the system requires
- □ Confirm the appointment slot has been obtained, and assign a dedicated person to track the SMS notification
- □ Confirm the notarisation and consular legalisation of the FSC and the letter of authorisation are complete (allow 4 to 6 weeks, practical estimate)
- □ Clarify who attends the on-site submission and prepare the authorisation documents
- □ Prepare the complete set of original documents, consistent with the electronic attachments
- □ Monitor JFDA announcements on electronic service upgrades and adjust the submission method in time
- □ Verify the cited article numbers against the Arabic original of the official gazette
- □ Regulatory information verified as of 29 October 2026
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Jordanian market. Our team manages JFDA registration applications, prepares reference-approval dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzan.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us